| Breakdown | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.29B | 2.19B | 1.80B | 2.52B | 3.20B |
| Gross Profit | 525.17M | 889.99M | 901.99M | 1.30B | 719.12M |
| EBITDA | 280.61M | 918.86M | 235.54M | 868.46M | 390.87M |
| Net Income | -419.42M | -267.66M | -584.70M | -283.88M | -675.57M |
Balance Sheet | |||||
| Total Assets | 28.59B | 28.47B | 30.12B | 33.78B | 35.14B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 1.01B | 1.65B | 2.11B | 2.82B |
| Total Debt | 10.26B | 9.81B | 10.57B | 11.89B | 11.54B |
| Total Liabilities | 16.24B | 15.76B | 17.61B | 19.32B | 19.69B |
| Stockholders Equity | 12.03B | 12.32B | 12.78B | 14.61B | 15.43B |
Cash Flow | |||||
| Free Cash Flow | 292.17M | 342.64M | 553.26M | 238.23M | 1.38B |
| Operating Cash Flow | 320.90M | 394.71M | 626.41M | 407.38M | 1.65B |
| Investing Cash Flow | -22.07M | -261.62M | 798.02M | -907.80M | -1.19B |
| Financing Cash Flow | -281.25M | -749.85M | -1.77B | -118.37M | 1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
49 Neutral | HK$547.48M | 0.05 | 260.87% | ― | 82.96% | ― | |
45 Neutral | HK$317.79M | -0.77 | -3.45% | ― | -39.37% | -56.69% | |
42 Neutral | HK$240.24M | -0.10 | -34.31% | ― | -63.41% | 77.97% | |
41 Neutral | HK$198.48M | -0.03 | ― | ― | -45.56% | -191.99% | |
40 Underperform | HK$156.10M | -0.01 | 73.75% | ― | -62.71% | -16.95% | |
39 Underperform | HK$426.17M | 0.33 | -21.15% | ― | 69.55% | 64.09% |
Lai Fung Holdings has warned that its unaudited consolidated loss attributable to shareholders for the six months ended 31 January 2026 will be at least double the HK$164 million loss recorded a year earlier. The company attributed the deeper interim loss mainly to a loss on the sale of an accommodation tower and a write-down of properties in the Hengqin Novotown Phase II project.
The board stressed that the figures are based on preliminary, unaudited management accounts, with full interim results due for release on 24 March 2026. In light of the sharp expected deterioration in earnings and one-off project-related charges, the company urged shareholders and potential investors to exercise caution when dealing in its shares, underscoring heightened execution and valuation risks around its Hengqin assets.
The most recent analyst rating on (HK:1125) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on Lai Fung Holdings stock, see the HK:1125 Stock Forecast page.
Lai Fung Holdings has scheduled a board meeting for 24 March 2026 to review and approve the unaudited interim results for the six months ended 31 January 2026. The board will also consider whether to declare an interim dividend, a decision that could directly affect shareholder returns and signal management’s confidence in the company’s near-term financial performance.
By formally flagging the timing of its results review and potential dividend decision, the company is providing investors with visibility on upcoming financial disclosures. This announcement helps set expectations for the market regarding the company’s interim earnings and capital distribution policy, which are key indicators watched closely by stakeholders.
The most recent analyst rating on (HK:1125) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on Lai Fung Holdings stock, see the HK:1125 Stock Forecast page.
Lai Fung Holdings said its operations have remained normal since the resumption of trading in its shares in November 2022, but its public float currently stands at about 14.76%, below the 25% level required under Hong Kong listing rules. The company plans to continue talks with controlling shareholders, core connected persons and financial advisers to restore compliance, and will issue monthly updates on its public float status and adhere to other applicable listing requirements, while cautioning investors to exercise care when dealing in its shares.
The most recent analyst rating on (HK:1125) stock is a Sell with a HK$1.00 price target. To see the full list of analyst forecasts on Lai Fung Holdings stock, see the HK:1125 Stock Forecast page.
Lai Fung Holdings has provided an update on its ongoing failure to meet the Hong Kong Stock Exchange’s minimum public float requirement after two individual investors, Mr. Yu Cheuk Yi and Ms. Yu Siu Yuk, accumulated more than 10% of its shares in May 2022, thereby becoming substantial shareholders and core connected persons and causing the public float to drop from about 24.77% to around 14.75%. Trading in the company’s shares was suspended in June 2022 and later resumed, but despite exploring multiple avenues—including potential sell-downs by its controlling shareholders, discussions with core connected persons about disposing shares, and engagement of financial advisers to consider options such as placements, rights issues and scrip dividends—the board concluded that a meaningful disposal by its parent companies would be against their and their shareholders’ interests, and that structural, market and governance constraints, alongside the YUs’ unwillingness to engage, have so far prevented Lai Fung from restoring compliance with public float rules, prolonging regulatory uncertainty for investors.
The most recent analyst rating on (HK:1125) stock is a Sell with a HK$0.85 price target. To see the full list of analyst forecasts on Lai Fung Holdings stock, see the HK:1125 Stock Forecast page.
Lai Fung Holdings Limited reported that all resolutions proposed at its annual general meeting held on 19 December 2025 were duly approved by shareholders by way of poll, including the adoption of the audited financial statements for the year ended 31 July 2025 and the re-election of four directors, two executive and two independent non-executive, with overwhelming support. Shareholders also authorised the board to fix directors’ remuneration, confirmed the re-appointment of Ernst & Young as independent auditor despite a notable minority opposing vote, and granted the board general mandates to repurchase up to 10% of issued shares and to issue up to 20% new shares with an extension for repurchased shares, collectively reinforcing the company’s capital management flexibility and continuity in governance and oversight.
The most recent analyst rating on (HK:1125) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Lai Fung Holdings stock, see the HK:1125 Stock Forecast page.